Herriott Simon
Known title: President Health & BiosciencesCIK: 0001843592
Associated companies
Transaction History
| IFF | ▲ Buy | Grant | 237 | $0 | 3/4/2025 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 86 | $7K | 3/4/2025 | View on chart |
| IFF | ▲ Buy | Option Exercise | 627 | $0 | 7/3/2024 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 289 | $27K | 7/3/2024 | View on chart |
| IFF | ▲ Buy | Option Exercise | 1,591 | $0 | 5/3/2024 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 493 | $43K | 5/3/2024 | View on chart |
| IFF | ▲ Buy | Option Exercise | 1,244 | $0 | 4/5/2024 | View on chart |
| IFF | ▲ Buy | Option Exercise | 346 | $0 | 4/5/2024 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 108 | $9K | 4/5/2024 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 386 | $32K | 4/5/2024 | View on chart |
| IFF | ▲ Buy | Option Exercise | 1,489 | $0 | 4/1/2024 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 461 | $40K | 4/1/2024 | View on chart |
| IFF | ▲ Buy | Grant | 286 | $0 | 3/1/2024 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 104 | $8K | 3/1/2024 | View on chart |
| IFF | ▲ Buy | Option Exercise | 1,489 | $0 | 4/1/2023 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 461 | $42K | 4/1/2023 | View on chart |
| IFF | ▲ Buy | Option Exercise | 617 | $0 | 2/19/2023 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 177 | $17K | 2/19/2023 | View on chart |
| IFF | ▲ Buy | Option Exercise | 616 | $0 | 2/19/2022 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 155 | $21K | 2/19/2022 | View on chart |
| IFF | ▲ Buy | Option Exercise | 525 | $0 | 2/14/2022 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 132 | $17K | 2/14/2022 | View on chart |
| IFF | ▲ Buy | Option Exercise | 3,241 | $0 | 12/31/2021 | View on chart |
| IFF | ▼ Sell | Tax Withholding | 891 | $133K | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
IFF to Report Q3 2026 Results on November 3
International Flavors & Fragrances is scheduled to release its third-quarter 2026 earnings on November 3, 2026. This upcoming report is the primary driver of recent attention for the stock. The company's shares have been trading near the upper end of their 52-week range, with an RSI of 75.3 suggesting strong recent momentum ahead of the announcement.
IFF to Report Q3 2026 Results on November 3. International Flavors & Fragrances is scheduled to release its third-quarter 2026 earnings on November 3, 2026. This upcoming report is the primary driver of recent attention for the stock. The company's shares have been trading near the upper end of their 52-week range, with an RSI of 75.3 suggesting strong recent momentum ahead of the announcement.